Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Bioeconomy

Main navigation

  • Start page
  • Bioeconomy in BW

    Bioeconomy in BW

    Close
    • What is a bioeconomy?
      • Perspectives on the bioeconomy
      • Processes and technologies in the bioeconomy
      • Bioeconomy products
    • Bioeconomy in BW
      • Start-up funding
    • Bioeconomy stakeholders in BW
      • BW and its companies
      • BW and its researchers
      • BW and its networks
  • Articles

    Articles

    Close
    • News
    • Press releases
    • Dossiers
    • Biobased resources
    • Bioenergy
    • Materials and chemicals
    • Politics, ethics & economy
    • Environmental analytics
    • Publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • Information channels
    • Contacts
    • BIOPRO services and offers
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 24/06/2009 The photo shows four pictures – origin-CFP, DnaA-YFP, DnaX-RFG and overlay, including three photos showing Bacillus subtilis cells under the fluorescence microscope. The bars indicate the dividing walls between the cells. The left photo shows the coupling of the origin areas with CFP; the green glow shows the location of the areas at the cell poles. The second photo shows the location of DnaA in the centre of the cells, coupled with red fluorescing YFP. The third photo shows the components of the replication machinery in yellow. The photo on the right shows an overlay of the three photos.

    The initiation of replication – only once, please

    DNA replication is a critical event in the cell division process. The genetic material must only be replicated once. So, how does a bacterial cell ensure that only one single replication occurs and that the process is not repeated several times? Microbiologists under the leadership of Prof. Dr. Peter Graumann from the Institute of Biology II in Freiburg, in cooperation with international cooperation partners from Paris, have deciphered a…

    https://www.biooekonomie-bw.de/en/articles/news/the-initiation-of-replication-only-once-please
  • Article - 23/06/2009 The reverse transcriptase (RT) is part of a protein complex known as P protein. This also involves the terminal protein (TP) and RNase H (RH) domains. Protein P forms a complex with pre-genomic RNA (pgRNA) by binding to the epsilon loop (ε). The terminal protein then creates the DNA primer (red).

    Hepatitis B and the Münchhausen enzyme

    Virologists in Prof. Dr. Michael Nassals group at the University Medical Centre in Freiburg are investigating the molecular mechanisms used by the hepatitis B virus to reproduce. The researchers work might in future be able to help the three to four hundred million people worldwide who suffer from chronic hepatitis B infections.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hepatitis-b-and-the-muenchhausen-enzyme
  • Article - 22/06/2009 Microscopic detection of two melanoma cells (stained blue) in a sentinel lymph node – the new method now enables a quantitative statement to be made about the tumour load.

    New method enables the early and reliable detection of metastatic melanoma cells

    The presence of lymph node metastases has a considerable effect on the prognosis and therapy of patients with malignant melanomas. Therefore the histopathological examination of what are known as sentinel lymph nodes the first lymph nodes that metastasising cancer cells reach is of great importance. However the examination method has its technical limitations where very small metastases are concerned. Professor Dr. Anja Ulmer a dermatologist at…

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-method-enables-the-early-and-reliable-detection-of-metastatic-melanoma-cells
  • Article - 22/06/2009 08862_de.jpg

    Scientists with entrepreneurial spirit

    Dr. Brigitte Angres and Dr. Helmut Wurst have been thinking about establishing their own company for a long time. The Californian biotech company Clontech, where the two scientists worked for several years, will serve as their model now that the two scientists have found an excellent environment for turning their business idea into reality. This environment is the NMI in Reutlingen.

    https://www.gesundheitsindustrie-bw.de/en/article/news/scientists-with-entrepreneurial-spirit
  • Press release - 22/06/2009 08887_de.jpg

    Many animal experiments are superfluous

    Researchers at the Esslingen University of Applied Sciences are working on an alternative to the large number of animal experiments that are still being carried out. Researchers under the leadership of Prof. Dr. Bettina Weiß have received a grant from the Landesstiftung Baden-Württemberg foundation for work on this particular research area.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/many-animal-experiments-are-superfluous
  • Press release - 22/06/2009 Green fluorescent cells - on the left with cell extensions, on the right rather rounded.

    New important triggers for the migration of cancer cells

    Embryonic cells and metastasising cancer cells are able to migrate and intrude into other tissues. Investigations of frog embryos have now provided scientists at the Karlsruhe Institute of Technology with the information that a well-known protein, cadherin-11, triggers cell migration. This glycoprotein is also responsible for the defective behaviour of cells that results in prostate cancer and arthritis.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-important-triggers-for-the-migration-of-cancer-cells
  • Press release - 22/06/2009 08265_de.jpg

    SYGNIS makes further progress in the 2008/2009 fiscal year

    SYGNIS Pharma AG announced the results of the 2008/2009 fiscal year, which ended on 31 March 2009 and presented the milestones of the reporting period. On the way to becoming a product-based pharmaceutical company specialising in the treatment of disorders of the central nervous system (CNS), SYGNIS has taken further steps forward. One of the key milestones of the reporting period is the completion of the preparations for the multinational phase…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/sygnis-makes-further-progress-in-the-2008-2009-fiscal-year
  • Press release - 22/06/2009 Logo of BioRN

    Successful start: cooperative projects of the Rhine-Neckar Biotechnology Cluster (BioRN)

    The first joint public appearance of the numerous players of the BioRN top cluster underlines the importance of cooperations between industry and science. At the first annual BioRN conference the Cell-based and molecular medicine top cluster announced the successful start of five cooperative projects funded by the German Federal Ministry of Education and Research. In a strategy workshop the companies involved in the projects presented all 36…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/successful-start-cooperative-projects-of-the-rhine-neckar-biotechnology-cluster-biorn
  • Press release - 22/06/2009

    Science2Start: The initial hurdles of company foundation can be overcome

    In scientists’ heads and desk drawers there exists a mine of dormant ideas that could be turned into commercially successful products according to Dr. Kathrin Ballesteros-Katemann, project manager at BioRegio STERN Management GmbH in Stuttgart. However, a lack of business know-how and the reluctance to take the first step are often major impediments when it comes to becoming self-employed. The Science2Start project now offers such scientists a…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/science2start-the-initial-hurdles-of-company-foundation-can-be-overcome
  • Press release - 22/06/2009 08704_de.jpg

    MRI for tracing living cells

    Researchers from the Mannheim Medical Faculty which is part of Heidelberg University and the Max Planck Institute MPI for Biological Cybernetics in Tübingen have achieved a world first in the use of magnetic resonance imaging MRI for the simultaneous visualisation of sodium and potassium ions which are important for proper cell function in the living cell. The scientists from the Mannheim Medical Faculty have thus achieved an important milestone…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mri-for-tracing-living-cells
  • Article - 19/06/2009 Leucobacter spec. under the electron microscope

    Bacteria with a chromium envelope

    Heavy metals have become a huge problem for mankind. The construction of factories and the varnishing of cars leads to the contamination of soils and waters and therefore also to the poisoning of many organisms including people. Scientists are trying to use natural means to remove inorganic chemicals from the cycle or at least make them harmless. Dr. Johannes Gescher and his team at the Department of Microbiology at the University of Freiburg…

    https://www.biooekonomie-bw.de/en/articles/news/bacteria-with-a-chromium-envelope
  • Article - 15/06/2009 08835_de.jpg

    Leena Bruckner-Tuderman – how the skin functions

    Leena Bruckner-Tuderman from the Department of Dermatology at the University Medical Centre in Freiburg has just been awarded the Eva Luise Köhler Research Prize for Rare Diseases. She has not only made a decisive contribution to the clarification of the molecular causes of the skin disease “dystrophic epidermolysis bullosa”, but has also begun focusing on potential clinical therapies. Prof. Dr. Leena Bruckner-Tuderman from Finland has worked at…

    https://www.gesundheitsindustrie-bw.de/en/article/news/leena-bruckner-tuderman-how-the-skin-functions
  • Article - 10/06/2009 08801_de.jpg

    Colleagues who became customers

    Should they work with a long-standing cooperation partner or should they set up another company that was the decision faced by the staff of the Discovery-IT department of Nycomed formerly ALTANA Pharma in the spring of 2007.

    https://www.gesundheitsindustrie-bw.de/en/article/news/colleagues-who-became-customers
  • Article - 10/06/2009 Portrait of Dr Dirk Linke

    Dirk Linke - a vaccine is ready - just in case

    There is a well-known saying: travel broadens the mind. This is not the only consequence of travel – the biochemist Dr. Dirk Linke from Tübingen travelled to India on holiday and brought back an idea for a new scientific project. Since his return, his idea, the possibility of developing a vaccine with a wide-ranging effect against some of the most frequent diarrhoea pathogens, has even generated financial backing from prominent supporters.

    https://www.gesundheitsindustrie-bw.de/en/article/news/dirk-linke-a-vaccine-is-ready-just-in-case
  • Press release - 10/06/2009 08818_de.jpg

    6.56 million euros for first full-body PET-MRI prototype

    The Joint Science Conference in Bonn has announced that the University of Tübingen will receive 6.56 million euros for the purchase of an entirely new multimodal full-body tomography system for the diagnosis of cancer. The new full-body PET-MRI combines positron emission tomography PET with magnetic resonance imaging MRI in one device.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/6-56-million-euros-for-first-full-body-pet-mri-prototype
  • Press release - 10/06/2009 Cells growing in a coated, three-dimensional glass scaffold

    New Research Programme BioInterfaces launched

    The research center Karlsruhe of the Helmholtz Association and the University of Karlsruhe are represented in the Karlsruhe Institute of Technology. The programme BioInterfaces brings together a team of scientist of several fields to build up a link between science and teachings. 67 research teams develop with an annual budget of approximately 20 Million Euro innovative tools and technologies for precisely controlling the behaviour of cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-research-programme-biointerfaces-launched
  • Article - 10/06/2009 Group photo of Interquer AG. Anja Honegger (in the front), Jessica Ebner and Vera Schnepf (2nd row from left to right), Johanna Klees and Ralitsa Atanasova (3rd row from left to right), Joachim Koepff and Filippo Venezia (last row from left to right); not present: Lena Stachorski

    Student initiative supports intercultural exchange

    A small work group of eight technical biologists at Stuttgart University has been contributing to international exchange since 2006. Interquer AG is a student-initiated project that has the objective of providing support for the re-integration of national and international guest students as well as transfer students early entrance students and students who return to their studies after a long illness. The Interquer AG students who act as mentors…

    https://www.gesundheitsindustrie-bw.de/en/article/news/student-initiative-supports-intercultural-exchange
  • Press release - 10/06/2009 08834_de.jpg

    New tests for and new data about the new influenza type

    In Germany, test methods that enable the identification of an infection caused by the new influenza A/H1N1 virus, even after the symptoms have subsided or disappeared completely, have become available for the first time. The National Influenza Reference Centre (NRZ) at the Robert Koch Institute has developed two serological tests based on the detection of antibodies in the blood serum. The antibodies are produced about 2 weeks after onset of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-tests-for-and-new-data-about-the-new-influenza-type
  • Press release - 10/06/2009 08838_de.jpg

    University of Ulm to receive Draeger Prize for best publication in 2008

    The Hospital of Anaesthesiology at Ulm University has been awarded the Draeger Prize by the European Society for Anaesthesiology for the best publication in the field of intensive care medicine in 2008. The university’s press office explained that the award-winning publication was a report on a two-year project investigating the effects of pure oxygen breathing to treat septic circulatory shock. The prize comes with a cheque of 10,000 euros.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-of-ulm-to-receive-draeger-prize-for-best-publication-in-2008
  • Article - 09/06/2009 08813_de.jpg

    We would gladly finance more biotechs

    For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…

    https://www.gesundheitsindustrie-bw.de/en/article/news/we-would-gladly-finance-more-biotechs
  • Article - 09/06/2009 08813_de.jpg

    We would gladly finance more biotechs

    For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…

    https://www.biooekonomie-bw.de/en/articles/news/we-would-gladly-finance-more-biotechs
  • Article - 03/06/2009 08768_de.jpg

    Quality management for biotech companies?

    What kind of permits and certification do young biotech companies need? Do particular requirements in the quality assurance of production processes based on initial permits still have to be taken into account 10 years after foundation? Ten years on, it may in fact be necessary to obtain different certificates that take external factors into account as well as changes in a company’s product and service portfolio. But what do ISO 9001, ISO 13485,…

    https://www.gesundheitsindustrie-bw.de/en/article/news/quality-management-for-biotech-companies
  • Press release - 03/06/2009 Two coated cotton dental rolls are shown.

    Hohenstein Institute develops textile that releases medicinal gasses

    The Institute for Hygiene and Biotechnology (IHB) at Hohenstein has developed the first textile that can release medically effective gasses. The textile was developed at the IHB under the auspices of a broader research project. The textile will be used in future therapeutic applications.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hohenstein-institute-develops-textile-that-releases-medicinal-gasses
  • Article - 29/05/2009 08642_de.jpg

    ITV Denkendorf – Hi-tech think tank for textiles

    The Institute of Textile Technology and Process Engineering Denkendorf ITV Denkendorf is Germanys largest and oldest textile research centre. Research is carried out in specialised laboratories and technical centres covering the entire range of textiles from raw materials to the final product both in basic as well as applied research.

    https://www.gesundheitsindustrie-bw.de/en/article/news/itv-denkendorf-hi-tech-think-tank-for-textiles
  • Article - 29/05/2009 08642_de.jpg

    ITV Denkendorf – Hi-tech think tank for textiles

    The Institute of Textile Technology and Process Engineering Denkendorf ITV Denkendorf is Germanys largest and oldest textile research centre. Research is carried out in specialised laboratories and technical centres covering the entire range of textiles from raw materials to the final product both in basic as well as applied research.

    https://www.biooekonomie-bw.de/en/articles/news/itv-denkendorf-hi-tech-think-tank-for-textiles

Page 133 / 164

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 164
  • eine Seite zurück
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Bioeconomy in BW
    • What is a bioeconomy?
    • Bioeconomy in BW
    • Bioeconomy stakeholders in BW
  • Articles
    • News
    • Press releases
    • Dossiers
    • Biobased resources
    • Bioenergy
    • Materials and chemicals
    • Politics, ethics & economy
    • Environmental analytics
    • Publications
  • Events
  • Databases
    • Funding
    • Research institutions
  • BIOPRO services
    • Information channels
    • Contacts
    • BIOPRO services and offers
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.biooekonomie-bw.de/en/search